Search Results - "Arun, J"

Past, present and future perspectives in nonalcoholic fatty liver disease by Sanyal, Arun J.

“…Nonalcoholic fatty liver disease (NAFLD) was first described as a distinct clinical entity four decades ago. However, the condition has become the centre of…”
Get full text

Current and upcoming pharmacotherapy for non-alcoholic fatty liver disease by Rotman, Yaron, Sanyal, Arun J

“…Given the high prevalence and rising incidence of non-alcoholic fatty liver disease (NAFLD), the absence of approved therapies is striking. Although the…”
Get more information

Identification of plant leaf diseases using a nine-layer deep convolutional neural network by G, Geetharamani, J, Arun Pandian

“…•We proposed a 9-layer deep convolutional neural network for leaf disease identification.•We used six different types of image augmentation methods, and…”
Get full text

Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease by Estes, Chris, Razavi, Homie, Loomba, Rohit, Younossi, Zobair, Sanyal, Arun J.

“…Nonalcoholic fatty liver disease (NAFLD) and resulting nonalcoholic steatohepatitis (NASH) are highly prevalent in the United States, where they are a growing…”
Get full text

The global NAFLD epidemic by Loomba, Rohit, Sanyal, Arun J.

“…Global differences in the prevalence and presentation of NAFLD are presented in this Perspectives article. The authors also convey how scientific advances in…”
Get full text

Mechanisms of NAFLD development and therapeutic strategies by Friedman, Scott L., Neuschwander-Tetri, Brent A., Rinella, Mary, Sanyal, Arun J.

“…There has been a rise in the prevalence of nonalcoholic fatty liver disease (NAFLD), paralleling a worldwide increase in diabetes and metabolic syndrome…”
Get full text

Toward More Accurate Nomenclature for Fatty Liver Diseases by Eslam, Mohammed, Sanyal, Arun J., George, Jacob

Get full text

Therapeutic pipeline in nonalcoholic steatohepatitis by Vuppalanchi, Raj, Noureddin, Mazen, Alkhouri, Naim, Sanyal, Arun J.

“…Our understanding of nonalcoholic fatty liver disease pathophysiology continues to advance rapidly. Accordingly, the field has moved from describing the…”
Get full text

A Placebo-Controlled Trial of Subcutaneous Semaglutide in Nonalcoholic Steatohepatitis by Newsome, Philip N, Buchholtz, Kristine, Cusi, Kenneth, Linder, Martin, Okanoue, Takeshi, Ratziu, Vlad, Sanyal, Arun J, Sejling, Anne-Sophie, Harrison, Stephen A

“…Patients with nonalcoholic steatohepatitis were randomly assigned to receive subcutaneous semaglutide or placebo. The incidence of NASH resolution was…”
Get full text

Therapies in non‐alcoholic steatohepatitis (NASH) by Oseini, Abdul M., Sanyal, Arun J.

“…The hallmark of non‐alcoholic fatty liver disease (NAFLD) is excessive fatty accumulation in the hepatocytes, which may be an isolated event (non‐alcoholic…”
Get full text

The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases by Chalasani, Naga, Younossi, Zobair, Lavine, Joel E., Charlton, Michael, Cusi, Kenneth, Rinella, Mary, Harrison, Stephen A., Brunt, Elizabeth M., Sanyal, Arun J.

Get full text

NASH: A global health problem by Sanyal, Arun J.

“…Non‐alcoholic fatty liver disease (NAFLD) is a major public health problem both in the Western world and in the East. This is mainly due to the high prevalence…”
Get full text

From NAFLD to MAFLD: Implications of a Premature Change in Terminology by Younossi, Zobair M., Rinella, Mary E., Sanyal, Arun J., Harrison, Stephen A., Brunt, Elizabeth M., Goodman, Zachary, Cohen, David E., Loomba, Rohit

“…Despite the substantial gains in our understanding of NAFLD/NASH over the past 2 decades, there has been some dissatisfaction with the terminology…”
Get full text

Nonalcoholic fatty liver disease as a metabolic disease in humans: A literature review by Cariou, Bertrand, Byrne, Christopher D., Loomba, Rohit, Sanyal, Arun J.

“…Aims To conduct a systematic literature review to identify recent epidemiological, biomarker, genetic and clinical evidence that expands our understanding of…”
Get full text

Molecular Mechanisms of Lipotoxicity and Glucotoxicity in Nonalcoholic Fatty Liver Disease by Mota, Manoela, Banini, Bubu A, Cazanave, Sophie C, Sanyal, Arun J

“…Abstract The exposure of hepatocytes to high concentrations of lipids and carbohydrates and the ensuing hepatocellular injury are termed lipotoxicity and…”
Get full text

Preclinical models of non-alcoholic fatty liver disease by Santhekadur, Prasanna K., Kumar, Divya P., Sanyal, Arun J.

“…Non-alcoholic fatty liver disease (NAFLD) can manifest as non-alcoholic fatty liver (NAFL) or non-alcoholic steatohepatitis (NASH). NASH is often associated…”
Get full text

Management of NAFLD: a stage-based approach by Rinella, Mary E., Sanyal, Arun J.

“…Key Points NAFLD is the most common cause of liver disease, affecting 30% of the US population; however, the goals of treatment differ based on stage of…”
Get full text

The Diagnosis and Management of Non-alcoholic Fatty Liver Disease: Practice Guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology by Chalasani, Naga, MD, FACG, Younossi, Zobair, MD, FACG, Lavine, Joel E., MD, PhD, Diehl, Anna Mae, MD, Brunt, Elizabeth M., MD, Cusi, Kenneth, MD, Charlton, Michael, MD, Sanyal, Arun J., MD

Get full text

Noninvasive Assessment of Liver Fibrosis in NAFLD by Sanyal, Arun J., Castera, Laurent, Wong, Vincent Wai-Sun

“…Nonalcoholic fatty liver disease (NAFLD) has emerged as a leading cause of liver-related morbidity and mortality worldwide, afflicting approximately a billion…”
Get full text

The Etiology of Hepatocellular Carcinoma and Consequences for Treatment by Sanyal, Arun J., Yoon, Seung Kew, Lencioni, Riccardo

“…Most patients with hepatocellular carcinoma (HCC) have liver cirrhosis, which develops following long periods of chronic liver disease. Cirrhosis is…”
Get full text